Adenoviral vector which delivers FasL-GFP fusion protein regulated by the tet-inducible expression system

Gene Therapy

Volumn 7, Issue 10, 2000, Pages 875-885

  Rubinchik, S ^a,b   Ding, R ^a   Qiu, A J ^a   Zhang, F ^a   Dong, J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Adenoviral vector; Apoptosis; Fas ligand; Regulated expression; Regulation

Indexed keywords

FAS LIGAND; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; TETRACYCLINE; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; GENE INDUCTION; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOVIRIDAE; DNA VIRUSES; MURINAE;

EID: 0034124055     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301172     Document Type: Article

References (47)

1. Takahashi T et al. Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol 1994; 6: 1567-1574.
2. Bajorath J, Aruffo A. Prediction of the three-dimensional structure of the human Fas receptor by comparative molecular modeling. J Comput Aided Mol Des 1997; 11: 3-8.
3. Watanabe-Fukunaga R et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992; 148: 1274-1279.
4. Ogasawara J et al. Lethal effect of the anti-Fas antibody in mice (published erratum appears in Nature 1993 Oct 7; 365 (6446): 568). Nature 1993; 364: 806-809.
5. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-1456.
6. Larsen CP et al. Fas-mediated cytotoxicity. An immunoeffector or immunoregulatory pathway in T cell-mediated immune responses? Transplantation 1995; 60: 221-224.
7. Longthorne VL, Williams GT. Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO J 1997; 16: 3805-3812.
8. Watanabe-Fukunaga R et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314-317.
9. Golstein P. Fas-based T cell-mediated cytotoxicity. Curr Top Microbiol Immunol 1995; 198: 25-37.
10. Berke G. The Fas-based mechanism of lymphocytotoxicity. Hum Immunol 1997; 54: 1-7.
11. Tanaka M, Itai T, Adachi M, Nagata S. Downregulation of Fas ligand by shedding (see comments). Nature Med 1998; 4: 31-36.
12. Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J 1995; 14: 1129-1135.
13. Green DR, Ware CF. Fas-ligand: privilege and peril (see comments). Proc Natl Acad Sci USA 1997; 94: 5986-5990.
14. Griffith TS et al. Fas ligand-induced apoptosis as a mechanism of immune privilege (see comments). Science 1995; 270: 1189-1192.
15. Guller S. Role of Fas ligand in conferring immune privilege to non-lymphoid cells. Ann NY Acad Sci 1997; 828: 268-272.
16. Hahne M et al. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape (see comments). Science 1996; 274: 1363-1366.
17. Strand S et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? (see comments). Nature Med 1996; 2: 1361-1366.
18. Saas P et al. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J Clin Invest 1997; 99: 1173-1178.
19. Srinivasan A et al. Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells. J Biol Chem 1998; 273: 4523-4529.
20. Owen-Schaub LB et al. Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis? Cancer Lett 1995; 94: 1-8.
21. Cascino I, Papoff G, Eramo A, Ruberti G. Soluble Fas/Apo-1 splicing variants and apoptosis. Front Biosci 1996; 1: d12-18.
22. Judge TA et al. Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survival. Transplantation 1998; 66: 426-434.
23. Sata M et al. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc Natl Acad Sci USA 1998; 95: 1213-1217.
24. Swenson KM et al. Fas ligand gene transfer to renal allografts in rats: effects on allograft survival. Transplantation 1998; 65: 155-160.
25. Zhang HG et al. Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells (see comments). Nat Biotechnol 1998; 16: 1045-1049.
26. Zhang HG et al. Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression. J Virol 1998; 72: 2483-2490.
27. Arai H, Gordon D, Nabel EG, Nabel GJ. Gene transfer of Fas ligand induces tumor regression in vivo. Proc Natl Acad Sci USA 1997; 94: 13862-13867.
28. Shiner M et al. Are intraepithelial lymphocytes in celiac mucosa responsible for inducing programmed cell death (apoptosis) in enterocytes? Histochemical demonstration of perforins in cytoplasmic granules of intraepithelial lymphocytes. J Pediatr Gastroenterol Nutr 1998; 27: 393-396.
29. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
30. Muruve DA et al. Adenovirus-mediated expression of Fas ligand induces hepatic apoptosis after systemic administration and apoptosis of ex vivo-infected pancreatic islet allografts and isografts. Hum Gene Ther 1997; 8: 955-963.
31. Harding TC et al. Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system (see comments). Nat Biotechnol 1998; 16: 553-555.
32. Hearing P, Shenk T. The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element. Cell 1983; 33: 695-703.
33. Shi Q, Wang Y, Worton R. Modulation of the specificity and activity of a cellular promoter in an adenoviral vector. Hum Gene Ther 1997; 8: 403-410.
34. Han J et al. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev 1996; 10: 461-477.
35. Larregina AT et al. FasL induces Fas/Apo1-mediated apoptosis in human embryonic kidney 293 cells routinely used to generate El-deleted adenoviral vectors. Gene Therapy 1998; 5: 563-568.
36. Tewari M, Dixit VM. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 1995; 270: 3255-3260.
37. Kang SM et al. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction (see comments). Nature Med 1997; 3: 738-743.
38. Shinoura N et al. Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells: implications for gene therapy (in process citation). Hum Gene Ther 1998; 9: 1983-1993.
39. Kang SM, Lin Z, Ascher NL, Stock PG. Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejection. Transplant Proc 1998; 30: 538-543.
40. Okuyama T et al. Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching system. Gene Therapy 1998; 5: 1047-1053.
41. Tanaka M et al. Fas ligand in human serum. Nature Med 1996; 2: 317-322.
42. Tewari M, Beidler DR, Dixit VM. CrmA-inhibitable cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein during Fas- and tumor necrosis factor-induced apoptosis. J Biol Chem 1995; 270: 18738-18741.
43. Moreno MB, Memon SA, Zacharchuk CM. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity. J Immunol 1996; 157: 3845-3849.
44. Memon SA, Moreno MB, Petrak D, Zacharchuk CM. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma. J Immunol 1995; 155: 4644-4652.
45. Zhang G, Gurtu V, Kain SR. An enhanced green fluorescent protein allows sensitive detection of gene transfer in mammalian cells. Biochem Biophys Res Commun 1996; 227: 707-711.
46. Huang MM, Hearing P. The adenovirus early region 4 open reading frame 6/7 protein regulates the DNA binding activity of the cellular transcription factor, E2F, through a direct complex. Genes Dev 1989; 3: 1699-1710.
47. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59-74.